Staar Surgical Co (STAA)
37.23
+3.36
(+9.92%)
USD |
NASDAQ |
Sep 27, 16:00
37.84
+0.61
(+1.64%)
After-Hours: 20:00
Staar Surgical SG&A Expense (TTM): 187.72M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 187.72M |
March 31, 2024 | 185.64M |
December 31, 2023 | 180.15M |
September 30, 2023 | 179.73M |
June 30, 2023 | 171.00M |
March 31, 2023 | 158.84M |
December 31, 2022 | 143.60M |
September 30, 2022 | 133.10M |
June 30, 2022 | 125.16M |
March 31, 2022 | 117.23M |
December 31, 2021 | 111.44M |
September 30, 2021 | 104.17M |
June 30, 2021 | 96.21M |
March 31, 2021 | 84.09M |
December 31, 2020 | 79.68M |
September 30, 2020 | 77.48M |
June 30, 2020 | 75.80M |
March 31, 2020 | 76.82M |
December 31, 2019 | 74.80M |
September 30, 2019 | 71.83M |
June 30, 2019 | 68.98M |
March 31, 2019 | 66.64M |
December 31, 2018 | 62.89M |
September 30, 2018 | 59.80M |
June 30, 2018 | 54.30M |
Date | Value |
---|---|
March 31, 2018 | 49.48M |
December 31, 2017 | 48.13M |
September 30, 2017 | 45.09M |
June 30, 2017 | 46.01M |
March 31, 2017 | 46.09M |
December 31, 2016 | 50.36M |
September 30, 2016 | 51.15M |
June 30, 2016 | 50.15M |
March 31, 2016 | 48.61M |
December 31, 2015 | 43.30M |
September 30, 2015 | 41.25M |
June 30, 2015 | 40.40M |
March 31, 2015 | 42.39M |
December 31, 2014 | 43.26M |
September 30, 2014 | 46.95M |
June 30, 2014 | 46.82M |
March 31, 2014 | 44.46M |
December 31, 2013 | 42.90M |
September 30, 2013 | 41.11M |
June 30, 2013 | 40.63M |
March 31, 2013 | 40.14M |
December 31, 2012 | 39.07M |
September 30, 2012 | 37.63M |
June 30, 2012 | 36.20M |
March 31, 2012 | 34.81M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
71.83M
Minimum
Sep 2019
187.72M
Maximum
Jun 2024
121.72M
Average
114.33M
Median
SG&A Expense (TTM) Benchmarks
The Cooper Companies Inc | 1.530B |
OrthoPediatrics Corp | 146.94M |
NexGel Inc | 4.484M |
Innovative Eyewear Inc | 7.117M |
Abbott Laboratories | 11.34B |